Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $41,194 | 1,228 | 50.5% |
| Travel and Lodging | $19,597 | 56 | 24.0% |
| Consulting Fee | $13,900 | 4 | 17.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,300 | 2 | 7.7% |
| Education | $342.81 | 4 | 0.4% |
| Long term medical supply or device loan | $281.66 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $21,484 | 195 | $0 (2024) |
| Philips Electronics North America Corporation | $16,047 | 160 | $0 (2023) |
| Medtronic Vascular, Inc. | $11,695 | 74 | $0 (2020) |
| Boston Scientific Corporation | $8,190 | 97 | $0 (2024) |
| Medtronic, Inc. | $4,695 | 49 | $0 (2024) |
| ABIOMED | $3,266 | 65 | $0 (2024) |
| Cardiovascular Systems Inc. | $2,782 | 42 | $0 (2022) |
| Penumbra, Inc. | $2,133 | 9 | $0 (2024) |
| Biosense Webster, Inc. | $1,614 | 21 | $0 (2024) |
| Edwards Lifesciences Corporation | $1,523 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,268 | 97 | Abbott Laboratories ($868.81) |
| 2023 | $5,929 | 84 | Penumbra, Inc. ($1,902) |
| 2022 | $6,865 | 113 | Medtronic, Inc. ($3,259) |
| 2021 | $5,459 | 145 | Abbott Laboratories ($2,130) |
| 2020 | $7,043 | 131 | Abbott Laboratories ($2,516) |
| 2019 | $25,285 | 223 | Philips Electronics North America Corporation ($10,166) |
| 2018 | $17,932 | 299 | Abbott Laboratories ($6,119) |
| 2017 | $8,835 | 203 | Medtronic Vascular, Inc. ($5,744) |
All Payment Transactions
1,295 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $73.97 | General |
| Category: Heart Failure | ||||||
| 12/13/2024 | Biosense Webster, Inc. | NA (Device) | Food and Beverage | In-kind items and services | $32.01 | General |
| Category: Ultrasound Catheters | ||||||
| 12/11/2024 | Medtronic, Inc. | SYMPLICITY G3 (Device) | Food and Beverage | In-kind items and services | $165.67 | General |
| Category: Renal Denervation System | ||||||
| 12/10/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $43.21 | General |
| Category: Lithoplasty | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/03/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Transcatheter Heart Valves | ||||||
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/25/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $24.36 | General |
| Category: Heart Failure and Hypertension | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $6.00 | General |
| Category: Cardiovascular | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $1.24 | General |
| Category: Cardiovascular | ||||||
| 11/14/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $32.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Abbott Laboratories | PORTICO (Device) | Food and Beverage | In-kind items and services | $144.80 | General |
| Category: Structural Heart | ||||||
| 10/30/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/28/2024 | Medtronic, Inc. | RESOLUTE ONYX (Device) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Stents | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.76 | General |
| Category: Cardiovascular | ||||||
| 10/23/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Edwards Lifesciences Corporation | SAPIEN 3 Ultra RESILIA (Device) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Transcatheter Heart Valves | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Cardiology | ||||||
| 10/10/2024 | Abbott Laboratories | PORTICO (Device) | Food and Beverage | In-kind items and services | $64.70 | General |
| Category: Structural Heart | ||||||
| 10/08/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.20 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | CARDIVA MEDICAL, INC. | OPTOWIRE (Device) | Food and Beverage | In-kind items and services | $48.26 | General |
| Category: DEVICES | ||||||
| 09/12/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $17.95 | General |
| Category: Cardiology | ||||||
| 09/11/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $38.02 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,418 | 3,271 | $833,217 | $290,698 |
| 2022 | 22 | 1,897 | 2,587 | $655,080 | $236,675 |
| 2021 | 20 | 1,722 | 2,544 | $891,132 | $242,359 |
| 2020 | 24 | 2,600 | 4,030 | $1.8M | $689,358 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 431 | 701 | $171,985 | $63,422 | 36.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 103 | 103 | $86,467 | $34,443 | 39.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 265 | 265 | $84,727 | $30,020 | 35.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 203 | 208 | $78,518 | $29,692 | 37.8% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 60 | 71 | $78,416 | $28,453 | 36.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 103 | 205 | $65,044 | $20,465 | 31.5% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 98 | 98 | $54,259 | $15,453 | 28.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 85 | 337 | $52,930 | $14,131 | 26.7% |
| 33340 | Repair of left upper heart chamber with implant with review by radiologist | Facility | 2023 | 22 | 22 | $32,659 | $13,030 | 39.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 495 | 638 | $17,903 | $6,549 | 36.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 105 | $15,648 | $6,257 | 40.0% |
| 33361 | Replacement of aortic valve through the skin and femoral artery | Facility | 2023 | 11 | 11 | $25,051 | $6,085 | 24.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 116 | 116 | $15,684 | $5,594 | 35.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 72 | 74 | $12,820 | $4,591 | 35.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 27 | $8,991 | $3,617 | 40.2% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 38 | 40 | $7,129 | $2,803 | 39.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 34 | 34 | $4,510 | $1,767 | 39.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 131 | 139 | $12,387 | $1,305 | 10.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,340 | $1,205 | 36.1% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 19 | 19 | $2,591 | $994.09 | 38.4% |
| 93248 | Heart rhythm review and interpretation of continous external ekg over 8-15 days | Office | 2023 | 23 | 25 | $1,258 | $478.32 | 38.0% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 20 | $900.00 | $343.71 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 301 | 467 | $122,869 | $42,869 | 34.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 102 | 102 | $93,968 | $34,275 | 36.5% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2022 | 50 | 60 | $70,754 | $26,051 | 36.8% |
About Dr. Nirav Mehta, MD
Dr. Nirav Mehta, MD is a Cardiovascular Disease healthcare provider based in Surprise, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801865415.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nirav Mehta, MD has received a total of $81,616 in payments from pharmaceutical and medical device companies, with $4,268 received in 2024. These payments were reported across 1,295 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($41,194).
As a Medicare-enrolled provider, Mehta has provided services to 8,637 Medicare beneficiaries, totaling 12,432 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology
- Location Surprise, AZ
- Active Since 03/16/2006
- Last Updated 08/27/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1801865415
Products in Payments
- Spectranetics Undiv (Device) $6,300
- Endeavor (Device) $5,354
- Xience V coronary stent system (Device) $5,314
- Asahi Fielder coronary guide wire (Device) $4,645
- RESOLUTE ONYX (Device) $3,876
- Impella (Device) $3,266
- WATCHMAN (Device) $3,184
- iFR (Device) $2,900
- Resolute (Device) $2,847
- CardioMEMS HF System (Device) $2,724
- IVUS Systems (Device) $2,612
- Indigo System (Device) $2,133
- ClosureFast (Device) $1,893
- Peripheral Orbital Atherectomy System (Device) $1,850
- HawkOne (Device) $1,463
- GENERAL THERAPIES (Device) $1,331
- Confirm Rx (Device) $1,126
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,080
- ENTRESTO (Drug) $1,013
- (6571) Eagle Eye (Device) $978.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.